Cormorant Asset Management, LP Diversified Active

Location: Boston, MA

CIK: 0001583977 · Show all filings

Period: Q2 2014 (← Previous) (Next →)

Filing Date: Aug 14, 2014

Total Value: $377M (100.0% shares, 0.0% debt)

Holdings (54)

RECEPTOS INC 5.4%
Value $20.4M Shares 478,800 Est. Cost $32.51 Unrealized
OMER OMEROS CORP 5.2%
Value $19.54M Shares 1,123,000 Est. Cost $12.47 Unrealized +1.2%
QUESTCOR PHARMACEUTICALS INC 4.9%
Value $18.5M Shares 200,000 Est. Cost $92.49 Unrealized
KARYOPHARM THERAPEUTICS INC 4.7%
Value $17.92M Shares 385,000 Est. Cost $33.09 Unrealized
DYAX CORP 4.6%
Value $17.28M Shares 1,800,000 Est. Cost $7.54 Unrealized
CELGENE CORP 4.6%
Value $17.18M Shares 200,000 Est. Cost $85.88 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 3.9%
Value $14.89M Shares 1,168,000 Est. Cost $9.67 Unrealized +0.6%
JAZZ JAZZ PHARMACEUTICALS PLC 3.9%
Value $14.7M Shares 100,000 Est. Cost $150.52 Unrealized -7.9%
PBYI PUMA BIOTECHNOLOGY INC 3.6%
Value $13.7M Shares 207,500 Est. Cost $60.82 Unrealized +16.9%
ARROWHEAD RESH CORP 3.4%
Value $12.88M Shares 900,000 Est. Cost $10.85 Unrealized
AKBA AKEBIA THERAPEUTICS INC 2.9%
Value $11.12M Shares 400,000 Est. Cost $24.08 Unrealized 0.0%
GALT GALECTIN THERAPEUTICS INC 2.9%
Value $11.05M Shares 800,000 Est. Cost $13.23 Unrealized -5.9%
TESARO INC 2.5%
Value $9.333M Shares 300,000 Est. Cost $28.24 Unrealized
HRTX HERON THERAPEUTICS INC 2.3%
Value $8.624M Shares 700,000 Est. Cost $11.95 Unrealized 0.0%
DXCM DEXCOM INC 2.1%
Value $7.932M Shares 200,000 Est. Cost $7.91 Unrealized +12.0%
SGMO SANGAMO BIOSCIENCES INC 2.0%
Value $7.635M Shares 500,000 Est. Cost $17.13 Unrealized -16.0%
MALLINCKRODT PUB LTD CO 1.9%
Value $7.202M Shares 90,000 Est. Cost $80.02 Unrealized
ACELRX PHARMACEUTICALS INC 1.9%
Value $7.175M Shares 700,000 Est. Cost $11.31 Unrealized
NOVAVAX INC 1.8%
Value $6.93M Shares 1,500,000 Est. Cost $4.95 Unrealized
ACCELERON PHARMA INC 1.8%
Value $6.794M Shares 200,000 Est. Cost $33.97 Unrealized
SRNE SORRENTO THERAPEUTICS INC 1.8%
Value $6.75M Shares 1,000,000 Est. Cost $10.01 Unrealized -24.7%
CHIMERIX INC 1.7%
Value $6.582M Shares 300,000 Est. Cost $19.16 Unrealized
PORTOLA PHARMACEUTICALS INC 1.5%
Value $5.836M Shares 200,000 Est. Cost $25.84 Unrealized
MRK MERCK & CO INC NEW 1.5%
Value $5.785M Shares 100,000 Est. Cost $35.76 Unrealized +6.2%
EGRX EAGLE PHARMACEUTICALS INC 1.5%
Value $5.732M Shares 400,000 Est. Cost $13.58 Unrealized -16.0%
VERSARTIS INC 1.5%
Value $5.608M Shares 200,000 Est. Cost $28.04 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL INC 1.4%
Value $5.387M Shares 120,000 Est. Cost $46.32 Unrealized -11.1%
APPLIED GENETIC TECHNOLOGIES 1.3%
Value $5.05M Shares 218,600 Est. Cost $23.10 Unrealized
ALKS ALKERMES PLC 1.3%
Value $5.033M Shares 100,000 Est. Cost $47.58 Unrealized -3.1%
ROCKWELL MED INC 1.3%
Value $4.796M Shares 400,000 Est. Cost $12.66 Unrealized
ARRAY BIOPHARMA INC 1.2%
Value $4.56M Shares 1,000,000 Est. Cost $5.01 Unrealized
PUMA BIOTECHNOLOGY INC 1.2%
Value $4.5M Shares 5,000 Est. Cost $900.00 Unrealized
NANOSTRING TECHNOLOGIES INC 1.2%
Value $4.485M Shares 300,000 Est. Cost $20.65 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 1.2%
Value $4.451M Shares 300,000 Est. Cost $14.11 Unrealized 0.0%
CHINA BIOLOGIC PRODS INC 1.2%
Value $4.447M Shares 100,000 Est. Cost $44.47 Unrealized
QUOTIENT LTD 1.1%
Value $4.18M Shares 500,000 Est. Cost $8.36 Unrealized
RECRO PHARMA INC 1.1%
Value $4.005M Shares 500,000 Est. Cost $7.32 Unrealized
GLYCOMIMETICS INC 1.1%
Value $3.981M Shares 472,300 Est. Cost $16.33 Unrealized
PTCT PTC THERAPEUTICS INC 1.0%
Value $3.921M Shares 150,000 Est. Cost $26.39 Unrealized -18.9%
GENVEC INC 0.9%
Value $3.416M Shares 1,329,300 Est. Cost $2.65 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 0.8%
Value $3.159M Shares 50,000 Est. Cost $59.65 Unrealized -0.4%
ALDER BIOPHARMACEUTICALS INC 0.8%
Value $3.011M Shares 150,000 Est. Cost $20.07 Unrealized
CLOVIS ONCOLOGY INC 0.8%
Value $2.899M Shares 70,000 Est. Cost $60.27 Unrealized
AGENUS INC 0.8%
Value $2.898M Shares 900,000 Est. Cost $3.17 Unrealized
AQUINOX PHARMACEUTICALS INC 0.7%
Value $2.829M Shares 300,000 Est. Cost $12.15 Unrealized
CERULEAN PHARMA INC 0.7%
Value $2.61M Shares 450,000 Est. Cost $5.80 Unrealized
AUSPEX PHARMACEUTICALS INC 0.6%
Value $2.227M Shares 100,000 Est. Cost $30.76 Unrealized
KINDRED BIOSCIENCES INC 0.5%
Value $1.864M Shares 100,000 Est. Cost $18.64 Unrealized
REGULUS THERAPEUTICS INC 0.4%
Value $1.608M Shares 200,000 Est. Cost $8.21 Unrealized
AGILE THERAPEUTICS INC 0.3%
Value $1.308M Shares 150,000 Est. Cost $8.72 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 0.3%
Value $1.13M Shares 50,000 Est. Cost $23.59 Unrealized -11.5%
CURIS INC 0.3%
Value $1.116M Shares 600,000 Est. Cost $1.86 Unrealized
SCYNEXIS INC 0.2%
Value $802K Shares 100,000 Est. Cost $8.02 Unrealized
CELSUS THERAPEUTICS PLC 0.2%
Value $639K Shares 103,000 Est. Cost $6.49 Unrealized